Collection
Applied Life Sciences: Exercise and Cancer
The number of people living with cancer or beyond is expected to increase as a result of better screening programs and advances in treatment. In addition to survival, efforts have begun to be directed at improving the quality of life and health of cancer survivors. With this goal in mind, exercise could have substantial potential to improve the short- and long-term effects of cancer treatments, such as fatigue, increased body fat, loss of physical fitness, and prevention of the development of cancer, other chronic diseases to which survivors may be exposed, risks such as diabetes and CVD, a reduction in the chances of recurrence, and a longer survival. Research now shows that exercise in cancer patients may have positive effects on a number of aspects of cancer survival, disease progression, prognosis, and quality of life. However, patients suffering from depression, fatigue, and weakness associated with cancer treatments may have difficulty finding a fitness program that works well for them. Integrative Cancer Therapies invites your research in this field of study for this Topical Collection.
Relevant topics may include:
- Exercise programs such as Pilates, chi gong and yoga
- Aerobic exercise and bone and muscle strengthening
- Exercise for various types of cancer
- Impact on treatment, side effects and quality of life
Keywords: cancer care; exercise; biomarkers; survivors; fatigue; quality of life
Editors
-
Diego Fernández-Lázaro
Diego Fernández-Lázaro, Ph.D., University of Valladolid, Spain. Dr. Diego Fernández-Lázaro is an assistant professor in the Department of Cellular Biology, Genetics, Histology and Pharmacology at the University of Valladolid. He is the Vice Dean of Academic Organization of the Faculty of Health Sciences of the University of Valladolid. Diego works in cancer research, sports medicine research and exercise physiology.
-
Julia Vidán Estévez
Julia Vidán Estévez, Ph.D., Complejo Asistencial Universitario de León (CAULE), Spain. Dra. Julia Vidán Estévez is Head of the Apheresis & Transfusion Unit, Department of Hematology & Hemotherapy, University Care Complex of León (Spain), and a member of Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Spain.
